Description
Carvelis (Crataegi Leaf) Oral Drops Solution 100 ml. Vial
Composition
The primary ingredient in Carvelis is Crataegi leaf, a natural extract known for its medicinal properties. Other inactive ingredients ensure the stability and effectiveness of the solution.
Mechanism of Action
Carvelis exerts its therapeutic effects through the active components present in Crataegi leaf, which are known to have positive impacts on cardiovascular health and overall well-being.
Pharmacological Properties
The pharmacological properties of Carvelis are attributed to the bioactive compounds found in Crataegi leaf, which have been studied for their cardiovascular benefits and potential therapeutic effects on mild to moderate health conditions.
Indications for Use
Carvelis is indicated for the management of mild to moderate health conditions under the supervision of a healthcare professional. It is also used as a supportive treatment for heart-related conditions to promote overall cardiovascular health.
Contraindications
Carvelis is contraindicated in patients with known hypersensitivity to Crataegi leaf or any other ingredient in the formulation. It is not recommended for use in children under 12 years of age unless specifically directed by a healthcare professional after a thorough evaluation of risks and benefits.
Side Effects
Common side effects of Carvelis may include gastrointestinal discomfort, allergic reactions in sensitive individuals, and rare cases of dizziness. It is important to consult a healthcare provider if any adverse reactions occur.
Usage Instructions
Prior to use, shake the vial well to ensure proper mixing of the solution. Administer the prescribed number of drops orally, either with or without food, as directed by a healthcare professional. It is crucial not to exceed the recommended dosage unless explicitly advised by a healthcare provider.
Benefits Compared to Analogues
Carvelis stands out from its analogues due to its natural composition derived from Crataegi leaf, which has a long history of traditional use in supporting cardiovascular health. The formulation of Carvelis ensures optimal bioavailability and efficacy compared to synthetic alternatives.
Suitable Patient Groups
Carvelis is suitable for adult patients seeking natural support for cardiovascular health. It is not recommended for use in children under 12 years of age unless under the close supervision of a healthcare professional who can assess the individual’s specific needs and health status.
Storage and Shelf Life
Store Carvelis in a cool, dry place away from direct sunlight. Ensure the cap is tightly closed after each use to prevent contamination. The shelf life of Carvelis is indicated on the packaging and should be strictly adhered to for optimal efficacy.
Packaging Description
Carvelis is available in a 100 ml vial containing the oral drops solution. The packaging is designed to maintain the stability and integrity of the product, ensuring that the therapeutic properties of Crataegi leaf are preserved until the last drop.
